Alpha 2.0

» Articles » PMID: 18948635

Loss of SR-A and CD36 Activity Reduces Atherosclerotic Lesion Complexity Without Abrogating Foam Cell Formation in Hyperlipidemic Mice

Overview

Overview

Journal Arterioscler Thromb Vasc Biol

Date 2008 Oct 25

PMID 18948635

Citations 130

Authors

Authors

Jennifer J Manning-Tobin

Kathryn J Moore

Tracie A Seimon

Susan A Bell

Maia Sharuk

Jacqueline I Alvarez-Leite

Menno P J de Winther

Ira Tabas

Mason W Freeman

Affiliations

Affiliations

Soon will be listed here.

Abstract

Objective: The scavenger receptors SR-A and CD36 have been implicated in macrophage foam cell formation during atherogenesis and in the regulation of inflammatory signaling pathways, including those leading to lesional macrophage apoptosis and plaque necrosis. To test the impact of deleting these receptors, we generated Apoe(-/-) mice lacking both SR-A and CD36 and fed them a Western diet for 12 weeks.

Methods And Results: We analyzed atheroma in mice, assessing lesion size, foam cell formation, inflammatory gene expression, apoptosis, and necrotic core formation. Aortic root atherosclerosis in Apoe(-/-)Cd36(-/-)Msr1(-/-) mice, as assessed by morphometry, electron microscopy, and immunohistochemistry, showed no decrease in lesion area or in vivo foam cell formation when compared to Apoe(-/-) mice. However, Apoe(-/-)Cd36(-/-)Msr1(-/-) lesions showed reduced expression of inflammatory genes and morphological analysis revealed a approximately 30% decrease in macrophage apoptosis and a striking approximately 50% decrease in plaque necrosis in aortic root lesions of these mice.

Conclusions: Although targeted deletion of SR-A and CD36 does not abrogate macrophage foam cell formation or substantially reduce atherosclerotic lesion area in Apoe(-/-) mice, loss of these pathways does reduce progression to more advanced necrotic lesions. These data suggest that targeted inhibition of these pathways in vivo may reduce lesional inflammation and promote plaque stability.

Citing Articles

Impacts of Variants on Plasma Lipid Levels and the Risk of Early-Onset Coronary Artery Disease: A Systematic Review and Meta-Analysis.

Luo Z, Lv L Cardiovasc Ther. 2025; 2025:8098173.

PMID: 40040886 PMC: 11879577. DOI: 10.1155/cdr/8098173.

Heterogeneous population of macrophages in the development of non-alcoholic fatty liver disease.

Cho Y, Kwon Y, Hwang S Liver Res. 2025; 7(1):16-25.

PMID: 39959694 PMC: 11791820. DOI: 10.1016/j.livres.2022.06.001.

The role of M1/M2 macrophage polarization in the pathogenesis of obesity-related kidney disease and related pathologies.

Dousdampanis P, Aggeletopoulou I, Mouzaki A Front Immunol. 2025; 15:1534823.

PMID: 39867890 PMC: 11758166. DOI: 10.3389/fimmu.2024.1534823.

-Coumaric acid modulates cholesterol efflux and lipid accumulation and inflammation in foam cells.

Moon H, Yun J Nutr Res Pract. 2024; 18(6):774-792.

PMID: 39651322 PMC: 11621437. DOI: 10.4162/nrp.2024.18.6.774.

Activation of receptor-independent fluid-phase pinocytosis promotes foamy monocyte formation in atherosclerotic mice.

Ahn W, Burnett F, Wojnar-Lason K, Doja J, Sreekumar A, Ghoshal P Redox Biol. 2024; 78:103423.

PMID: 39615283 PMC: 11647241. DOI: 10.1016/j.redox.2024.103423.

References

1.

Kuchibhotla S, Vanegas D, Kennedy D, Guy E, Nimako G, Morton R . Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II. Cardiovasc Res. 2007; 78(1):185-96. PMC: 2810680. DOI: 10.1093/cvr/cvm093. View

2.

Febbraio M, Podrez E, Smith J, Hajjar D, Hazen S, Hoff H . Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest. 2000; 105(8):1049-56. PMC: 300837. DOI: 10.1172/JCI9259. View

3.

Tabas I . Secretory sphingomyelinase. Chem Phys Lipids. 2000; 102(1-2):123-30. DOI: 10.1016/s0009-3084(99)00080-8. View

4.

Babaev V, Gleaves L, Carter K, Suzuki H, Kodama T, Fazio S . Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A. Arterioscler Thromb Vasc Biol. 2000; 20(12):2593-9. DOI: 10.1161/01.atv.20.12.2593. View

5.

Kunjathoor V, Chiu D, OBrien K, LeBoeuf R . Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis. Arterioscler Thromb Vasc Biol. 2002; 22(3):462-8. DOI: 10.1161/hq0302.105378. View

6.

Kruth H . Sequestration of aggregated low-density lipoproteins by macrophages. Curr Opin Lipidol. 2002; 13(5):483-8. DOI: 10.1097/00041433-200210000-00003. View

7.

Moore K, El Khoury J, Medeiros L, Terada K, Geula C, Luster A . A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J Biol Chem. 2002; 277(49):47373-9. DOI: 10.1074/jbc.M208788200. View

8.

Kunjathoor V, Febbraio M, Podrez E, Moore K, Andersson L, Koehn S . Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem. 2002; 277(51):49982-8. DOI: 10.1074/jbc.M209649200. View

9.

Feng B, Zhang D, Kuriakose G, Devlin C, Kockx M, Tabas I . Niemann-Pick C heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosis. Proc Natl Acad Sci U S A. 2003; 100(18):10423-8. PMC: 193577. DOI: 10.1073/pnas.1732494100. View

10.

Bjorkbacka H, Kunjathoor V, Moore K, Koehn S, Ordija C, Lee M . Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med. 2004; 10(4):416-21. DOI: 10.1038/nm1008. View

11.

Wooton-Kee C, Boyanovsky B, Nasser M, de Villiers W, Webb N . Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation. Arterioscler Thromb Vasc Biol. 2004; 24(4):762-7. DOI: 10.1161/01.ATV.0000122363.02961.c1. View

12.

Goldstein J, Ho Y, Basu S, Brown M . Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A. 1979; 76(1):333-7. PMC: 382933. DOI: 10.1073/pnas.76.1.333. View

13.

Gerrity R, Naito H . Ultrastructural identification of monocyte-derived foam cells in fatty streak lesions. Artery. 1980; 8(3):208-14. View

14.

Khoo J, Miller E, McLoughlin P, Steinberg D . Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis. 1988; 8(4):348-58. DOI: 10.1161/01.atv.8.4.348. View

15.

Endemann G, Stanton L, Madden K, Bryant C, WHITE R, Protter A . CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 1993; 268(16):11811-6. View

16.

Williams K, Tabas I . The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 1995; 15(5):551-61. PMC: 2924812. DOI: 10.1161/01.atv.15.5.551. View

17.

Kunjathoor V, Wilson D, LeBoeuf R . Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest. 1996; 97(7):1767-73. PMC: 507242. DOI: 10.1172/JCI118604. View

18.

Libby P, Geng Y, Aikawa M, Schoenbeck U, Mach F, Clinton S . Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol. 1996; 7(5):330-5. DOI: 10.1097/00041433-199610000-00012. View

19.

Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K . A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 1997; 386(6622):292-6. DOI: 10.1038/386292a0. View

20.

Zhang W, Gaynor P, Kruth H . Aggregated low density lipoprotein induces and enters surface-connected compartments of human monocyte-macrophages. Uptake occurs independently of the low density lipoprotein receptor. J Biol Chem. 1998; 272(50):31700-6. DOI: 10.1074/jbc.272.50.31700. View